Celladon
Celladon is a biotechnology company that focuses in the development of molecular therapies to treat heart failure.
10
Funding Rounds
$152.2m
Money raised
Overview
Celladon is a biotechnology company that focuses in the development of molecular therapies to treat heart failure.
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro*** Ha**** | - | - |
Funding series
Funding Series Analysis
The company Celladon has raised a total of $30m in funding over 10 rounds.
Key Insights:
- Celladon Series B round: $30m
- Celladon funding round, February 2012: $43m
- Celladon Venture round, November 2015: $39.5m
- Celladon Venture round, October 2013: $1.1m
- Celladon Venture round, May 2012: $10m
- Celladon Venture round, December 2011: $500k
- Celladon Venture round, September 2011: $250k
- Celladon Venture round, October 2010: $2.5m
- Celladon Venture round, December 2009: $3.5m
- Celladon Series C round, November 2009: $21.8m
Celladon Series B round
$30m
Celladon funding round, February 2012
$43m
Celladon Venture round, November 2015
$39.5m
Celladon Venture round, October 2013
$1.1m
Celladon Venture round, May 2012
$10m
Celladon Venture round, December 2011
$500k
Celladon Venture round, September 2011
$250k
Celladon Venture round, October 2010
$2.5m
Celladon Venture round, December 2009
$3.5m
Celladon Series C round, November 2009
$21.8m
Industries
Celladon is active in the following industries: